Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS 66045, USA.
Neurosci Lett. 2013 Jan 15;533:86-9. doi: 10.1016/j.neulet.2012.11.017. Epub 2012 Nov 21.
The reduction of methionine sulfoxide in proteins is facilitated by the methionine sulfoxide reductase (Msr) system. The Msr reduction activity is important for protecting cells from oxidative stress related damages. Indeed, we have recently shown that treatment of cells with N-acetyl-methionine sulfoxide can increase Msr activity and protect neuronal cells from amyloid beta toxicity. Thus, in search of other similar Msr-inducing molecules, we examined the effects of pergolide, pergolide sulfoxide, and S-adenosyl-methionine on Msr activity in neuronal cells. Treatment of neuronal cells with a physiological range of pergolide and pergolide sulfoxide (0.5-1.0 μM) caused an increase of about 40% in total Msr activity compared with non-treated control cells. This increase in activity correlated with similar increases in methionine sulfoxide reductase A protein expression levels. Similarly, treatment of cells with S-adenosyl methionine also increased cellular Msr activity, which was milder compared to increases induced by pergolide and pergolide sulfoxide. We found that all the examined compounds are able to increase cellular Msr activity to levels comparable to N-acetyl-methionine sulfoxide treatment. Pergolide, pergolide sulfoxide, and S-adenosyl methionine can cross the blood-brain barrier. Therefore, we hypothesize that they can be useful in the treatment of symptoms/pathologies that are associated with reduced Msr activity.
蛋白质中蛋氨酸亚砜的还原由蛋氨酸亚砜还原酶(Msr)系统来促进。Msr 的还原活性对于保护细胞免受与氧化应激相关的损伤非常重要。事实上,我们最近表明,用 N-乙酰蛋氨酸亚砜处理细胞可以增加 Msr 活性并保护神经元细胞免受淀粉样β毒性。因此,在寻找其他类似 Msr 诱导分子的过程中,我们研究了培高利特、培高利特亚砜和 S-腺苷甲硫氨酸对神经元细胞中 Msr 活性的影响。用生理范围内的培高利特和培高利特亚砜(0.5-1.0 μM)处理神经元细胞会使总 Msr 活性比未经处理的对照细胞增加约 40%。这种活性的增加与甲硫氨酸亚砜还原酶 A 蛋白表达水平的相似增加相关。同样,用 S-腺苷甲硫氨酸处理细胞也会增加细胞内 Msr 活性,与培高利特和培高利特亚砜诱导的增加相比,这种增加较为温和。我们发现,所有检查的化合物都能够将细胞内 Msr 活性提高到与 N-乙酰蛋氨酸亚砜处理相当的水平。培高利特、培高利特亚砜和 S-腺苷甲硫氨酸可以穿过血脑屏障。因此,我们假设它们可用于治疗与 Msr 活性降低相关的症状/病理。